Primary Acquired Nasolacrimal Duct Obstruction Clinical Trial
Official title:
External Dacryocystorhinostomy Versus Canalicular Silicone Intubation With Mitomycin C in Primary Acquired Nasolacrimal Duct Obstruction
| Verified date | December 2018 |
| Source | Menoufia University |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Interventional |
While external DCR is the gold standard procedure for primary NLDO as well as complicated cases, SI with MMC could achieve comparable success rates in primary acquired NLDO, hence should be considered as an alternative as a safe and minimally invasive procedure.
| Status | Completed |
| Enrollment | 56 |
| Est. completion date | July 31, 2014 |
| Est. primary completion date | July 1, 2014 |
| Accepts healthy volunteers | No |
| Gender | All |
| Age group | 21 Years to 60 Years |
| Eligibility |
Inclusion Criteria: - primary acquired NLDO Exclusion Criteria: - All other secondary causes of NLDO |
| Country | Name | City | State |
|---|---|---|---|
| n/a | |||
| Lead Sponsor | Collaborator |
|---|---|
| Menoufia University |
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Other | canalicular silicone intubation with MMC | patency of lacrimal passage was tested by height of tear meniscus and lacrimal syringing. On the basis of subjective and objective evaluation, patients were categorized into three groups: successful surgery (asymptomatic, normal tear meniscus and patent lacrimal system with syringing procedure), improvement (watery eye and/or discharge, moderate tear meniscus and partially patent lacrimal system with syringing procedure with mild regurgitation from the puncta) and failed surgery (watery eye and/or discharge, high tear meniscus and non-patent lacrimal system). | 2 years | |
| Primary | external DCR | patency of lacrimal passage was tested by height of tear meniscus and lacrimal syringing. On the basis of subjective and objective evaluation, patients were categorized into three groups: successful surgery (asymptomatic, normal tear meniscus and patent lacrimal system with syringing procedure), improvement (watery eye and/or discharge, moderate tear meniscus and partially patent lacrimal system with syringing procedure with mild regurgitation from the puncta) and failed surgery (watery eye and/or discharge, high tear meniscus and non-patent lacrimal system). | 2 years |